Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%
May 11, 2023 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, May 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma’s Annual Letter to Shareholders
December 20, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
April 25, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology...
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
April 05, 2022 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, April 05, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology...
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
July 20, 2021 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, July 20, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer
July 08, 2021 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, July 08, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
28.51% CAGR , mRNA Vaccines & Therapeutics Market Size, Share, significant growth Rate, Trends 2026 by Brandessence Market Research
December 15, 2020 07:39 ET
|
Brandessence Market Research and Consulting Private Limited
Pune, India, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The global demand for mRNA vaccines & therapeutics market size, in terms of revenue, was worth of USD 587.7 million in 2019 and is expected to...